Submission Details
| 510(k) Number | K143754 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 31, 2014 |
| Decision Date | September 21, 2015 |
| Days to Decision | 264 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K143754 is an FDA 510(k) clearance for the QUANTA Flash CCP3, QUANTA Flash CCP3 Calibrators, and QUANTA Flash CCP3, a Antibodies, Anti-cyclic Citrullinated Peptide (ccp) (Class II — Special Controls, product code NHX), submitted by Inova Diagnostics, Inc. (San Diego, US). The FDA issued a Cleared decision on September 21, 2015, 264 days after receiving the submission on December 31, 2014. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5775.
| 510(k) Number | K143754 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 31, 2014 |
| Decision Date | September 21, 2015 |
| Days to Decision | 264 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | NHX — Antibodies, Anti-cyclic Citrullinated Peptide (ccp) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5775 |
| Definition | The Device Is Used For The Detection Of Anti-cyclic Citrullinated Peptide (ccp) Antibodies In Human Serum Or Plasma As An Aid In The Diagnosis Of Rheumatoid Arthritis. |